Your session is about to expire
← Back to Search
Behavioral Intervention
Motivational Interviewing for Type 2 Diabetes Support (IRMIT Trial)
N/A
Waitlist Available
Led By Dean A Bricker, MD
Research Sponsored by Wright State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measured every 3 months up to 4 years.
Awards & highlights
IRMIT Trial Summary
This trial will train medical staff in how to better support African American patients with Type 2 diabetes for better health outcomes.
Who is the study for?
This trial is for Family Medicine and Internal Medicine residents at Wright State University. It's designed to help improve how doctors communicate with African American patients who have Type 2 diabetes, aiming to enhance their health outcomes.Check my eligibility
What is being tested?
The study tests a new way of training doctors using motivational interviewing techniques boosted by artificial intelligence. The goal is to see if this method can strengthen the doctor-patient relationship in a community health center setting.See study design
What are the potential side effects?
Since this trial involves educational training methods rather than medical or pharmaceutical interventions, there are no direct physical side effects expected from participating in the study.
IRMIT Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ measured every 3 months up to 4 years.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured every 3 months up to 4 years.
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Changes in perceptions of the patient-clinician relationship by patients of participating residents.
Secondary outcome measures
Changes in the "spirit of motivational interviewing" rating given to the resident by the facilitator in role plays in motivational interviewing practice.
Changes in the percentage of time the resident speaks in role plays in motivational interviewing practice.
Changes in the ratio of open-ended to closed-ended questions used by the resident in role plays in motivational interviewing practice.
+4 moreIRMIT Trial Design
1Treatment groups
Experimental Treatment
Group I: Enhanced Motivational Interviewing TrainingExperimental Treatment1 Intervention
Participating medical residents will all receive two successive interventions, motivational interviewing (MI) booster training and the use of a dashboard that provides MI metrics. The booster training will make use of an artificial intelligence tool developed by our study team, Real-time Assessment of Dialogue in Motivational Interviewing (ReadMI), that produces metrics on important conversational skills (e.g., talking time, use of open-ended questions). The dashboard will produce these metrics during clinical encounters as a way to provide cuing for the MI approach.
Find a Location
Who is running the clinical trial?
Wright State UniversityLead Sponsor
41 Previous Clinical Trials
54,882 Total Patients Enrolled
Five Rivers Health CentersUNKNOWN
1 Previous Clinical Trials
Kennesaw State UniversityOTHER
9 Previous Clinical Trials
412 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- Criterion: Medical residents at Wright State University in Family Medicine and Internal Medicine programs who will be asked to join the study.N/A
Research Study Groups:
This trial has the following groups:- Group 1: Enhanced Motivational Interviewing Training
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any openings still available to those wishing to participate in this experiment?
"Clinicaltrials.gov attests that this study is not actively seeking patients at the moment; it was first posted on February 1st 2024, and last updated on January 20th of 2023. Nevertheless, there are currently 779 other trials for which individuals can volunteer their participation."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger